OPK - オプコ・ヘルス (Opko Health Inc.)

OPKのニュース

   Are Options Traders Betting on a Big Move in OPKO Health (OPK) Stock?  2020/05/15 13:31:00 Zacks Investment Research
Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.
   OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates  2020/05/08 14:33:00 Zacks Investment Research
OPKO Health's (OPK) first-quarter results benefit from increase in RAYALDEE prescriptions.
   OPKO Health (OPK) to Report Q1 Earnings: What's in Store?  2020/05/04 14:59:00 Zacks Investment Research
OPKO Health's (OPK) first-quarter performance is likely to reflect solid performance from Products and RAYALDEE.
   Will OPKO Health (OPK) Report Negative Q1 Earnings? What You Should Know  2020/04/28 16:33:05 Zacks Investment Research
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020  2020/04/22 12:00:10 Yahoo Finance
OPKO Health, Inc. (NASDAQ: OPK) today provided an update on two abstracts regarding the global Phase 3 somatrogon pediatric trial evaluating somatrogon dosed once weekly in pre-pubertal children with growth hormone deficiency (GHD). The data from the two abstracts, which were previously accepted for
   Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report?  2019/12/05 16:31:07 Zacks Investment Research
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Here's Why You Should Hold on to OPKO Health (OPK) Stock Now  2019/11/22 08:26:00 Zacks Investment Research
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.
   Opko Health (OPK) Q3 2019 Earnings Call Transcript | The Motley Fool  2019/11/06 23:31:10 The Motley Fool
OPK earnings call for the period ending September 30, 2019.
   OPKO Health Enters Oversold Territory  2019/10/28 15:23:00 Zacks Investment Research
OPKO Health has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
   The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug  2019/10/25 11:12:03 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 24) AstraZeneca plc (NYSE: AZN ) (reacted to a beat-and-raise quarter) Edwards Lifesciences Corp (NYSE: EW )( reported better-than-expected third-quarter results) Frequency Therapeutics Inc (NASDAQ: FREQ ) (IPOed Oct. 3) GlaxoSmithKline plc (NYSE: GSK )(FDA approved expanded use of Zejula) Novo Nordisk A/S (NYSE: NVO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 24) Acorda Therapeutics Inc NASDAQ: ACOR) (announced restructuring plan, including the elimination of 25% of its workforce) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) bluebird bio Inc (NASDAQ: BLUE ) (announced resignation of chief strategy officer) Brickell Biotech Inc (NASDAQ: BBI ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Gritstone Oncology Inc (NASDAQ: GRTS ) KemPharm Inc (NASDAQ: KMPH ) MacroGenics Inc (NASDAQ: MGNX ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) OpGen Inc (NASDAQ: OPGN ) )(announcing pricing of previously-announced underwritten common stock offering) Opko Health Inc. (NASDAQ: OPK )(announced a follow-on offering) Orgenesis Inc (NASDAQ: ORGS ) Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN ) Titan Medical Inc. (NASDAQ: TMDI ) Stocks In Focus Melinta Gets FDA Nod For Baxdela Label Expansion; Launch to Be Delayed Due to Liquidity Concerns Melinta Therapeutics Inc (NASDAQ: MLNT ) announced FDA approval for Baxdela for the treatment of adult patients with community-acquired bacterial pneumonia, or CABP, caused by designated succeptible bacteria.
   Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report?  2019/12/05 16:31:07 Zacks Investment Research
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Here's Why You Should Hold on to OPKO Health (OPK) Stock Now  2019/11/22 08:26:00 Zacks Investment Research
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.
   Opko Health (OPK) Q3 2019 Earnings Call Transcript | The Motley Fool  2019/11/06 23:31:10 The Motley Fool
OPK earnings call for the period ending September 30, 2019.
   OPKO Health Enters Oversold Territory  2019/10/28 15:23:00 Zacks Investment Research
OPKO Health has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
   The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug  2019/10/25 11:12:03 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 24) AstraZeneca plc (NYSE: AZN ) (reacted to a beat-and-raise quarter) Edwards Lifesciences Corp (NYSE: EW )( reported better-than-expected third-quarter results) Frequency Therapeutics Inc (NASDAQ: FREQ ) (IPOed Oct. 3) GlaxoSmithKline plc (NYSE: GSK )(FDA approved expanded use of Zejula) Novo Nordisk A/S (NYSE: NVO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 24) Acorda Therapeutics Inc NASDAQ: ACOR) (announced restructuring plan, including the elimination of 25% of its workforce) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) bluebird bio Inc (NASDAQ: BLUE ) (announced resignation of chief strategy officer) Brickell Biotech Inc (NASDAQ: BBI ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Gritstone Oncology Inc (NASDAQ: GRTS ) KemPharm Inc (NASDAQ: KMPH ) MacroGenics Inc (NASDAQ: MGNX ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) OpGen Inc (NASDAQ: OPGN ) )(announcing pricing of previously-announced underwritten common stock offering) Opko Health Inc. (NASDAQ: OPK )(announced a follow-on offering) Orgenesis Inc (NASDAQ: ORGS ) Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN ) Titan Medical Inc. (NASDAQ: TMDI ) Stocks In Focus Melinta Gets FDA Nod For Baxdela Label Expansion; Launch to Be Delayed Due to Liquidity Concerns Melinta Therapeutics Inc (NASDAQ: MLNT ) announced FDA approval for Baxdela for the treatment of adult patients with community-acquired bacterial pneumonia, or CABP, caused by designated succeptible bacteria.

calendar